- Home
- PHH vs DBVT Comparison
PHH vs DBVT Comparison
Compare PHH & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- DBVT
- Stock Information
- Founded
- PHH 2016
- DBVT 2002
- Country
- PHH China
- DBVT France
- Employees
- PHH N/A
- DBVT N/A
- Industry
- PHH Package Goods/Cosmetics
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PHH Consumer Discretionary
- DBVT Health Care
- Exchange
- PHH Nasdaq
- DBVT Nasdaq
- Market Cap
- PHH 894.1M
- DBVT 250.5M
- IPO Year
- PHH 2024
- DBVT N/A
- Fundamental
- Price
- PHH $1.08
- DBVT $10.80
- Analyst Decision
- PHH
- DBVT Buy
- Analyst Count
- PHH 0
- DBVT 4
- Target Price
- PHH N/A
- DBVT $14.81
- AVG Volume (30 Days)
- PHH 2.8M
- DBVT 26.3K
- Earning Date
- PHH 01-01-0001
- DBVT 07-29-2025
- Dividend Yield
- PHH N/A
- DBVT N/A
- EPS Growth
- PHH N/A
- DBVT N/A
- EPS
- PHH 0.02
- DBVT N/A
- Revenue
- PHH $2,381,851.00
- DBVT $3,497,000.00
- Revenue This Year
- PHH N/A
- DBVT $1,700.53
- Revenue Next Year
- PHH N/A
- DBVT $535.67
- P/E Ratio
- PHH $60.08
- DBVT N/A
- Revenue Growth
- PHH N/A
- DBVT N/A
- 52 Week Low
- PHH $1.04
- DBVT $2.21
- 52 Week High
- PHH $41.49
- DBVT $12.78
- Technical
- Relative Strength Index (RSI)
- PHH N/A
- DBVT 58.42
- Support Level
- PHH N/A
- DBVT $10.53
- Resistance Level
- PHH N/A
- DBVT $11.33
- Average True Range (ATR)
- PHH 0.00
- DBVT 0.76
- MACD
- PHH 0.00
- DBVT 0.14
- Stochastic Oscillator
- PHH 0.00
- DBVT 65.90
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.